Recent publications published by researchers at the MRC WIMM.
3D Microtumors Representing Ovarian Cancer Minimal Residual Disease Respond to the Fatty Acid Oxidation Inhibitor Perhexiline.
Yang X. et al, (2025), Adv Healthc Mater
mTOR-mediated p62/SQSTM1 stabilization confers a robust survival mechanism for ovarian cancer
Tamura T. et al, (2025), Cancer Letters, 217565 - 217565
Self-interactive learning: Fusion and evolution of multi-scale histomorphology features for molecular traits prediction in computational pathology.
Hu Y. et al, (2025), Med Image Anal, 101
The surgical, histopathological characteristics, and survival outcome of ovarian clear cell carcinoma: a retrospective case series sharing the experience of a tertiary cancer centre.
El Tawab S. et al, (2024), Transl Cancer Res, 13, 5037 - 5049
Correction: Completing a genomic characterisation of microscopic tumour samples with copy number.
Nulsen J. et al, (2024), BMC Bioinformatics, 25
Completing a genomic characterisation of microscopic tumour samples with copy number.
Nulsen J. et al, (2023), BMC Bioinformatics, 24
The clinicopathological characteristics and survival outcomes of primary expansile vs. infiltrative mucinous ovarian adenocarcinoma: a retrospective study sharing the experience of a tertiary centre.
Nistor S. et al, (2023), Transl Cancer Res, 12, 2682 - 2692
Role of immunotherapy in ovarian cancer: a narrative review
AHMED A. et al, (2022), Gynecology and Pelvic Medicine
Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease.
Serra EG. et al, (2022), Nat Commun, 13
Author Correction: Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation.
Zheng Y. et al, (2022), Nat Commun, 13
SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers.
Lu Z. et al, (2022), J Clin Invest, 132
Investigation of the potential mechanisms underlying nuclear F-actin organization in ovarian cancer cells by high-throughput screening in combination with deep learning
AHMED A. et al, (2022), Frontiers in Cell and Developmental Biology
CIDER: an interpretable meta-clustering framework for single-cell RNA-seq data integration and evaluation
Hu Z. et al, (2021), Genome Biology, 22
Neoadjuvant chemotherapy induces genomic and transcriptomic changes in ovarian cancer.
Javellana M. et al, (2021), Cancer Res
Studying Müllerian duct anomalies - from cataloguing phenotypes to discovering causation.
Santana González L. et al, (2021), Dis Model Mech, 14
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells.
Artibani M. et al, (2021), JCI Insight